So this executive order, when does it get implemented? And it's very interesting that you said that generics will actually benefit out of it because the innovator prices are -- if it's going to really target the innovator pricing then just give some -- can you give some color on this...?
Muffled? Okay. Better now?
So just please indulge with me because I'm a new person in this industry. Post -COVID, we had about 3 years now. And if we take the second wave also in 2021, there would have been a significant addition to API capacity in India. So , I just wanted to get a bit of the macro landscape over here. And I mean, it's been great for the Americans to throw this Biosecure Act and get a large number of additional capacity globally for APIs. When does this sort of begin to get commoditized? And what are the Chinese doing to protect their turf?